Exploratory Study of Umbilical Cord Blood-Derived CAR-NK Cell Therapy Targeting TRBC1/2 for Relapsed/Refractory T-Cell Lymphoma
Second Affiliated Hospital, School of Medicine, Zhejiang University
Second Affiliated Hospital, School of Medicine, Zhejiang University
Mayo Clinic
National Institutes of Health Clinical Center (CC)
Incyte Corporation
Baylor College of Medicine
Treeline Biosciences, Inc.
SciTech Development, Inc.